Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Salim Abdool Karim; Kogieleum Naidoo; Anneke C. Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew L. Gray; Tanuja N. Gengiah; Gonasagrie Nair; Sheila Bamber; Aarthi Singh; Munira Khan; Jacqueline Pienaar; Wafaa Mahmoud El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, Salim
Grobler, Anneke C.
Gray, Andrew L.
Gengiah, Tanuja N.
El-Sadr, Wafaa Mahmoud
Abdool Karim, Quarraisha
- Permanent URL:
- Book/Journal Title:
- New England Journal of Medicine
- The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial.
- Publisher DOI:
- Item views: